Status:
COMPLETED
Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Lung Cancer
Lung Metastasis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of the study is to evaluate the effectiveness of radiofrequency ablation by pathological correlation and to characterize the tissue response after treatment of primary and secondary pulmon...
Detailed Description
Thermal ablation therapy is an increasingly performed technique in the local tumor treatment. Among these techniques, image-guided radiofrequency (RF) ablation attained widespread consideration in the...
Eligibility Criteria
Inclusion
- Signed informed consent for radiofrequency ablation and surgery
- Maximum of 3 lung tumors
- Maximum tumor size 5 cm
- Must be able to receive standard surgery
Exclusion
- Pathological coagulation tests
- Pregnant or breast feeding
- Maximum tumor size more than 5 cm
- Bilateral secondary lung cancer with more than 3 tumors
- Inoperable patient
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00610844
Start Date
April 1 2004
Last Update
February 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Diagnostic Radiology
Tübingen, Baden-Wurttemberg, Germany, 72076